Hikma Pharma Buys Minority Interest in Hubei Haosun Pharma

Hikma Pharmaceuticals said it purchased a significant minority interest in Hubei Haosun Pharmaceutical through the subscription of new equity for a cash consideration of $5 million.
RTTNews